Keep in mind that China has recently developed a product that has a 99% success rate.A little competition shouldn't hurt though and they aren't targeting the UK but more so China, US and Israel.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
